Dracen Pharmaceuticals

Baltimore, United States

Dracen Pharmaceuticals is a developer of novel glutamine antagonists created to deliver improved outcomes for cancer patients.

Aug 2023

Debt Financing

Health Care Pharmaceutical

Top Investors

OUP (Osage University Partners)Deerfieldi&i Prague

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Dracen Pharmaceuticals

Who are Dracen Pharmaceuticals's investors?

Dracen Pharmaceuticals's investors include OUP (Osage University Partners), Deerfield, i&i Prague.

Where is Dracen Pharmaceuticals headquartered?

Dracen Pharmaceuticals is headquartered in Baltimore, United States.

What does Dracen Pharmaceuticals do?

Dracen Pharmaceuticals is a developer of novel glutamine antagonists created to deliver improved outcomes for cancer patients.

What stage is Dracen Pharmaceuticals at?

Dracen Pharmaceuticals is at the Debt Financing stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated August 10, 2023.

MLA

"Dracen Pharmaceuticals — Funding & Investors." VCBacked, August 10, 2023, https://www.vcbacked.co/company/dracen-pharmaceuticals. Accessed July 1, 2026.

APA

VCBacked. (2023). Dracen Pharmaceuticals — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/dracen-pharmaceuticals

Wikipedia (cite web)

{{cite web |title=Dracen Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/dracen-pharmaceuticals |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated August 10, 2023.